FindTrial
Sign In

Pharmacokinetics and Effect of Magnesium Sulfate in Early Onset Severe Preeclamptic Patients

Pharmacokinetics and Effect of Magnesium Sulfate in Early Onset Severe Preeclamptic Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800017045
Enrollment
Unknown
Registered
2018-07-10
Start date
2018-08-01
Completion date
Unknown
Last updated
2018-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early Onset Severe Preeclampsia

Interventions

Case series:To use Magnesium Sulfate to treat Early Onset Severe Preeclampsia

Sponsors

Suzhou Hospital Affiliated to Nanjing Medical University/ Suzhou Municipal Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. To use Magnesium Sulfate to treat Early Onset Severe Preeclampsia decided by clinician; 2. Informed consent obtained; 3. no other complications of pregacy .

Exclusion criteria

Exclusion criteria: 1. Chronic hypertension with pregnancy; 2. Multiple pregnancy; 3. Pregnant with chronic underlying diseases such as heart, liver and kidney; 4. Cannot express oneself advocate a lawsuit correctly; 5. Incomplete information

Design outcomes

Primary

MeasureTime frame
blood concentration of magnesium;—

Secondary

MeasureTime frame
blood concentration of calcium;blood pressure;noninvasive hemodynamics index;—

Countries

China

Contacts

Public ContactYanxia YU

Suzhou Hospital Affiliated to Nanjing Medical University/ Suzhou Municipal Hospital

yuyxsz@163.com+86 15051404960

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026